Intensive Treatment of Adolescent Panic and Agoraphobia

青少年恐慌和广场恐惧症的强化治疗

• 批准号: 7350121
• 负责人: Donna B. Pincus
• 金额: $ 34.45万
• 依托单位: BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-03-17 至 2009-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7350121
• 关键词: Adolescence; Adolescent; Adult; Age of Onset; Agoraphobia; Anxiety; Anxiety Disorders; Back; Behavior Therapy; Behavioral; Child; Chronic; Clinical; Clinical Trials; Cognitive; Condition; Control Groups; Control Locus; Controlled Study; Development; Disruption; Effectiveness; Emotional; Exercise; Family; Family member; Goals; Impairment; Intervention; Length; Life; Link; Maintenance; Mental Depression; Other Therapy; Panic; Panic Disorder; Parenting behavior; Parents; Patients; Pharmacological Treatment; Psychological reinforcement; Purpose; Quality of life; Randomized; Relative (related person); Reporting; Research; Research Personnel; Schools; Staging; Stress; Symptoms; Time; Training; Treatment Protocols; Treatment Refusal; Variant; Waiting Lists; Wood material; aged; coping; day; experience; follow-up; panic disorder with agoraphobia; peer; treatment duration; treatment program

DESCRIPTION (provided by applicant): Panic Disorder with or without agoraphobia (PDA) in adolescents is prevalent, chronic, and associated with substantial impairment, including avoidance of school, disruption of peer involvement and avoidance of autonomous activities. Perhaps for this reason, PDA is associated with more depression in adolescents compared to other anxiety disorders. Effective treatments for PDA exist in adults. In a study nearing completion at our center, we are demonstrating that a developmental adaptation of an empirically supported cognitive-behavioral treatment for PDA is effective compared to a wait-list control group. However, a rather high percentage of adolescents have refused to enter the trial due mostly to the length and timing of sessions (weekly sessions for three months of treatment). Families reported wanting more immediate relief from the significant impairment and disruption of everyday activities their adolescents were experiencing. Further, parents were not significantly involved in treatment despite their eagerness to be involved. Substantial evidence now exists that the inclusion of parents in the treatment of adolescent PDA might provide additional clinical benefit. Finally, a substantial integrated situational and interoceptive exposure component was not included in adolescents' treatment. The purpose of this application is to evaluate the efficacy and acceptability of a brief, developmentally tailored eight-day intensive treatment for PDA in adolescents referred to as adolescent panic control treatment with exposure (APE) relative to a waitlist control group and to explore the relative impact of involving parents directly in treatment. Ninety patients aged 12-17 will be randomly assigned to one of three conditions: intensive treatment including family members, intensive treatment without family members, or a waitlist control group. The specific goals of this project are: (1) to evaluate the efficacy of intensive APE for reducing symptoms of PDA in adolescents, (2) to assess long term durability of effects at 3, 6, and 12 months following treatment, (3) to assess the relative advantage of involving parents in treatment, (4) to assess the impact of treatment on impairment and quality of life of adolescents and their families, and (5) to analyze hypothesized mechanisms of change.

描述(由申请者提供)：恐慌症伴或不伴广场恐惧症(PDA)在青少年中很普遍，是慢性的，并与实质性的损害有关，包括逃学、中断同伴参与和避免自主活动。也许出于这个原因，与其他焦虑症相比，PDA与青少年更多的抑郁有关。成人存在有效的治疗PDA的方法。在我们中心即将完成的一项研究中，我们正在证明，与等待名单对照组相比，经验支持的认知行为疗法对PDA的发育适应是有效的。然而，相当高比例的青少年拒绝参加试验，主要原因是疗程的长度和时间安排(每周一次，为期三个月的疗程)。家庭报告说，他们希望从青少年正在经历的日常活动的严重损害和中断中获得更多直接的缓解。此外，尽管父母渴望参与治疗，但他们并没有显著参与治疗。现在有大量证据表明，将父母纳入青少年PDA的治疗可能会提供额外的临床益处。最后，在对青少年的治疗中没有包括大量整合的情境和感觉间暴露部分。本申请的目的是评估一种针对青少年PDA的简短、量身定制的为期8天的强化治疗，称为青少年惊恐控制暴露治疗(APE)相对于等待名单对照组的有效性和可接受性，并探讨父母直接参与治疗的相对影响。90名12-17岁的患者将被随机分配到三种情况中的一种：包括家庭成员的强化治疗，没有家庭成员的强化治疗，或等待名单对照组。本项目的具体目标是：(1)评估强化APE对减轻青少年PDA症状的有效性，(2)评估治疗后3、6和12个月效果的长期持久性，(3)评估让父母参与治疗的相对优势，(4)评估治疗对青少年及其家庭的损害和生活质量的影响，以及(5)分析假想的变化机制。